[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients

Summary

To investigate the radioactive uptake of \[Al 18 F\]PSMA137 in PCa patients, and evaluate the ability of \[Al 18 F\]PSMA137 to detect PSMA overexpression in PCa patients (especially those with recurrent or advanced PCa).To provide an approach for screening patients high expression of PSMA, efficacy monitoring, drug resistance and early warning of recurrence and metastasis to achieve the individualized antitumor treatment of targeted drugs.

Timeline

Start

2021-01-15

Primary completion

2024-06-12

Completion

2024-12-12

Drugs

Indications